"Designing Growth Strategies is in our DNA"

Acne Treatment Market Size, Share & COVID-19 Impact Analysis, By Product (Retinoids, Antibiotics, Isotretinoin, and Others), By Route of Administration (Oral and Topical), By Age Group (10 to 17 Years, 18 to 44 Years, 45 to 64 Years, and 65 Years & Above), By Distribution Channel (Hospital Pharmacies and Retail & Online Pharmacies), and Regional Forecast, 2023-2030

Region : Global | Format: PDF | Report ID: FBI103361

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The global acne treatment market size was valued at USD 10.48 billion in 2022 and the market is projected to grow from USD 11.09 billion in 2023 to USD 15.70 billion by 2030, exhibiting a CAGR of 5.1% during the forecast period.


Acne is a skin condition that arises when hair follicles get clogged with dead skin cells and oil. This condition is most common among teenagers, although it affects people of all ages. The most common medications are antibiotics, retinoids, and retinoid-like drugs. The increasing prevalence of skin disorders is one of the major factors augmenting the demand for acne treatment products globally during the forecast period.



  • For instance, according to the National Center for Biotechnology Information (NCBI), the prevalence of acne affected 9.4% of the global population in 2022. It is the eighth most prevalent disease in the world.


COVID-19 IMPACT


Loss of Revenue in Drug Usage Experienced due to Decline in Patient Visits during COVID-19 Pandemic


The pandemic staggered the growth of drugs used to treat acne due to the reduced number of patients seeking treatment globally. Dominant players in the market reported severe losses in revenues due to COVID-19. Additionally, decreased production, redistribution of healthcare expenditure, disrupted supply chains, the closing of dermatology clinics, and other factors affected the sales of drugs, especially during 2020. For instance, a study conducted with dermatologists in the U.S. by the American Association of Dermatology reported an almost 43% decline in weekly patient consultations during the lockdown period compared to the pre-COVID-19 level.


However, later in 2021, patient visits to hospitals and clinics started increasing as the regulations imposed by governments were relaxed resulting in increasing patient numbers. Additionally, the increased cases of acne associated with prolonged use of medical face masks also supported the demand for drugs during the pandemic and post-pandemic years. For instance, according to an article published in HCPLive in August 2022, 50% of the survey respondents (healthcare providers) in Romania reported acne lesions during the COVID-19 pandemic.


LATEST TRENDS 


Request a Free sample to learn more about this report.


Growing Clinical Approval of Drugs to Drive Market Growth


Rising prevalence of the condition among teenagers and adults has caught the attention of manufacturers, thereby boosting the demand for medications for acne treatment. Drug development focuses on the challenge of treating acne effectively and safely. For instance, the U.S. Food and Drug Administration (FDA) has given the nod for the new abbreviated drug application for topical retinoid adapalene gel USP 0.3%, manufactured by Alembic Pharmaceuticals for treating acne vulgaris. Similarly, in June 2022, Zydus Lifesciences received the U.S. FDA approval for the marketing of Adapalene and Benzoyl Peroxide topical gel in the U.S. This generic drug is used to treat acne.


Additionally, in January 2022, GALDERMA announced that it received antitrust clearance from the U.S. authorities and completed the acquisition of ALASTIN Skincare, Inc. to develop innovative and clinically-tested physician-dispensed skincare products.


DRIVING FACTORS


Rising Acne Prevalence Globally to Propel Market Growth


Globally, the prevalence of skin conditions has increased significantly. According to the American Association of Dermatology, in 2022, more than 50 million people in the U.S. will suffer from acne. Therefore, the number of patients opting for the treatment is increasing rapidly in developing and developed countries in North America, Europe, and Asia Pacific.


The introduction of various products used for the treatment, such as retinoids, isotretinoids, and antibiotics in oral and topical forms, is increasing awareness about acne products and available treatment options in the global population. Thus, increasing patient awareness is projected to propel market growth.


Launch of Novel Drugs to Propel Growth of the Market


The demand for effective drugs to treat this condition is rising due to the growing prevalence of the condition globally. Thus, the key companies are focusing on introducing novel drugs to meet the demand, which is the key trend for the market growth.



  • In July 2022, Glenmark Pharmaceuticals launched a new acne drug, MINYM gel, in India. This is India’s first topical Minocycline 4% Gel to treat acne.

  • In September 2021, Mayne Pharma Group Limited announced the launch of isotretinoin capsules, 10 mg, 20 mg, 30 mg, and 40 mg. In the U.S., isotretinoin capsules are a generic version of ABSORICA indicated to treat severe recalcitrant nodular acne.

  • In June 2020, Bausch Health Companies Inc. launched ARAZLO lotion in the U.S. for patients nine years of age and older suffering from acne vulgaris.

  • In March 2020, COSMEDIX, a global trailblazer in skincare products, announced the correct rapid relief acne treatment.


Moreover, efficient product marketing to intrigue the target population is another significant factor in increasing market growth. For instance, in March 2020, Derma Group launched a new website for Acne Ultra Clear.


RESTRAINING FACTORS


Side Effects Pertaining to Current Marketed Drugs is Limiting Adoption


Despite the higher prevalence of chronic acne globally, certain factors limit the adoption of acne treatment options. Among them is the side effect associated with drugs. According to the National Center for Biotechnology Information (NCBI), nausea, vomiting, or diarrhea are the most commonly seen side effects of antibiotics and are observed in around 7% of the total patients taking tetracycline and 4% of the patients taking macrolides.


The U.S. Food and Drug Administration (FDA) alerts about the usage of certain Over-the-Counter (OTC) medications that can cause potentially life-threatening allergic reactions or severe irritation. Additionally, antibiotics, such as tetracycline and clindamycin, which are majorly used to treat this condition, may create antibiotic resistance in the patients, which is projected to limit the market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), more than 2.8 million people in the U.S. have observed antibiotic resistance.


SEGMENTATION


By Product Analysis


To know how our report can help streamline your business, Speak to Analyst


High Efficiency for Treatment of Acne to Propel Growth of Antibiotics Segment


The market is divided into antibiotics, retinoids, isotretinoin, and others based on product.


The antibiotics segment held a dominant share of the market in 2022. This is attributable to the growing approval of antibiotics for acne treatment, along with their high efficiency in exudate management. Thus, antibiotics dominate the global market and are regarded as the highest shareowner regarding worth.


The retinoids segment is projected to register a higher CAGR by 2030, owing to the rising prevalence of moderate to severe acne and rising demand for retinoids. For instance, in February 2020, Sun Pharmaceutical Industries Ltd. announced the launch of ABSORICA LD (Isotretinoin) capsules in the U.S. to manage severe recalcitrant nodular acne in patients 12 years of age and older.


By Route of Administration Analysis


Easy Availability of OTC Topical Products Globally to Dominate Market Share 


The market is divided into topical and oral in terms of route of administration.


The topical segment dominated the market in 2022 and is expected to maintain its dominance across the forecast timeframe. The growth is attributable to the increasing number of companies manufacturing topical solutions for acne treatment. This is attributed to the patient population suffering from the condition, which is primarily intrigued by topical solutions as these products are easily available and comfortable.



  • For instance, in October 2022, the new skincare brand AcneSquad introduced a new product range for the treatment of acne. These topical products include toners, tonics, and serums, among others.


The oral segment is anticipated to project a significant CAGR during the forecast period due to an increase in the condition's prevalence and the growing number of product launches. For instance, in January 2019, Almirall, S.A. launched Seysara, the first oral antibiotic that has been specifically developed for use in acne in the U.S.


By Age Group Analysis


Rising Incidence of the Condition among Adults is Attributed to the Dominance of the 18 to 44 Years Segment 


The market is fragmented into 10 to 17 years, 18 to 44 years, 45 to 64 years, and 65 years & above, as per age group.


The 18 to 44 years segment is expected to have a dominant share in the market during the forecast period. The dominance is due to increase in the patient population of this particular age group.


The 10 to 17 years segment is estimated to witness considerable growth across the forecast period owing to the increasing incidence of acne vulgaris amongst the mentioned teenage group.


By Distribution Channel Analysis


Rising Demand for OTC Products to Lead to Retail & Online Pharmacies Segment’s Lucrative Growth Rate


Based on distribution channel, the market is bifurcated into retail & online pharmacies and hospital pharmacies.


The retail & online pharmacies segment is expected to witness a lucrative growth rate during the forecast period. This is due to the increasing number of online portals and websites commercializing acne treatment products, such as Walmart, Amazon, and several others. Moreover, the growing demand for OTC drugs will strongly support the growth of this segment.


The hospital pharmacies segment is estimated to hold a significant share during the forecast period due to an increase in hospital consultations to treat this disease.


REGIONAL INSIGHTS


North America Acne Treatment Market Size, 2022 (USD billion)

To get more information on the regional analysis of this market, Request a Free sample


Based on region, the market is segmented into Europe, North America, Asia Pacific, the Middle East & Africa, and Latin America.  


The market size in North America stood at USD 5.16 billion in 2022. The region's dominance is attributable to the increasing prevalence of acne across the region and the rising concerns related to beauty among the population. Thus, major players are introducing new drugs in the North American market. For instance, in November 2021, Sun Pharma launched Winlevi, a cream for the treatment of the condition, in the U.S. Additionally, factors such as a significant rise in the patient population, increasing awareness regarding advanced treatments, and the presence of major brands contributed to the high demand of products leading to the region’s superiority globally.


Europe will account for the second most prominent shareholder due to the increasing patient pool in the region, strong investment in R&D for the drugs used for the treatment of dermatology conditions by the major companies, and increased adoption of advanced treatment products.


Asia Pacific is estimated to register the highest CAGR due to rising awareness among the population about several drugs combined with the increasing number of companies entering the Asia market. For instance, in July 2022, Sun Pharmaceutical Industries expanded its collaboration with Cassiopea to supply WINLEVI in Australia, Japan, and New Zealand, along with three other countries.


Latin America will witness a significantly stable CAGR during the forecast owing to the rising prevalence of moderate to severe acne in the region and the rising recognition of the treatment.


The Middle East & Africa will occupy a smaller acne treatment market share and register a moderate CAGR since the market is still budding. Additionally, consumers' rising adoption of drugs will lead to growth during the forecast period.


KEY INDUSTRY PLAYERS


Focus on Inorganic Growth Strategies Propelled Allergan and Botanix Pharmaceuticals to Lead Global Market


The market is characterized by a large number of major players offering various types of drugs. The prominent companies will have a strong revenue position coupled with a diversified product portfolio of acne treatment drugs. These companies have a robust stronghold in the pivotal growth regions, and some dominant players include Allergan, Galderma S.A., and Bausch Health Companies Inc. For instance, In April 2021, Bausch Health Companies Inc. announced significant topline results from its Phase 3 trials for IDP-126 Gel to treat acne vulgaris. Additionally, in December 2022, the same company announced the availability of ARAZLO, a new treatment for acne vulgaris to patients through the provincial public drug plans in Canada.


The competitive landscape further encompasses companies of a smaller size that offer limited products for their offerings. These companies contain a strong national and local presence, such as Botanix Pharmaceuticals and Valeant Pharmaceutical International, Inc., and are expected to amplify their expansion during the forecast period.


LIST OF KEY COMPANIES PROFILED:



  • ABBVIE INC. (Ireland)

  • Botanix Pharmaceuticals (Australia)

  • GALDERMA (Switzerland)

  • Bausch Health Companies Inc. (U.S.) 

  • GlaxoSmithKline Plc. (U.K.)

  • Bayer AG (Germany)

  • Johnson & Johnson Services, Inc. (U.S.)

  • Pfizer Inc. (U.S.)

  • Teva Pharmaceutical Industries Ltd. (Israel)


KEY INDUSTRY DEVELOPMENTS:



  • December 2022 - Beiersdorf AG announced the acquisition of a Belgium company, S-Biomedic NV, to strengthen its expertise in the market.

  • March 2022 – Galderma introduced its breakthrough skincare cream, Twyneo to treat moderate to severe facial acne, to the U.S. market at the American Academy of Dermatology (AAD) Annual Meeting.

  • September 2022 - La Roche-Posay introduced Effaclar Salicylic Acid Acne Treatment Serum specifically for the treatment of adult acne.

  • January 2022 – GALDERMA announced to receive its antitrust clearance from the U.S. authorities after completing the acquisition of ALASTIN Skincare, Inc. for developing innovative and clinically-tested physician-dispensed skincare products.

  • January 2021 – GlaxoSmithKline plc announced that it agreed with Eligo BioScience to advance Eligobiotics for the treatment and prevention of Acne Vulgaris with CRISPR-based therapeutics for strain-specific microbiome modulation.


REPORT COVERAGE


An Infographic Representation of Acne Treatment Market

To get information on various segments, share your queries with us



The global market research report provides a detailed analysis of the market. It focuses on key aspects such as market size & forecast, critical regions for 2019-2030, new product launches, pipeline analysis, and an overview of technological developments. It also focuses on key aspects such as leading companies, products, and distribution channels. Besides this, the report offers insights into the acne treatment market trends and highlights key industry developments. In addition to the factors mentioned above, the report encompasses several factors that have contributed to the market growth in recent years.


Report Scope & Segmentation 






























































  ATTRIBUTE



  DETAILS



Study Period



2019-2030



Base Year



2022



Estimated Year



2023



Forecast Period



2023-2030



Historical Period



2019-2021



Growth Rate



CAGR of 5.1% from 2023-2030



Unit



Value (USD Billion)



Segmentation



By Product, Route of Administration, Age Group, Distribution Channel, and Geography



By Product




  • Retinoids

  • Antibiotics

  • Isotretinoin

  • Others



By Route of Administration




  • Oral

  • Topical



By Age Group




  • 10 to 17 Years

  • 18 to 44 Years

  • 45 to 64 Years

  • 65 Years & Above



By Distribution Channel




  • Hospital Pharmacies

  • Retail & Online Pharmacies



By Geography




  • North America (By Product, By Route of Administration, By Age Group, By Distribution Channel, and By Country)


    • U.S. (By Product)

    • Canada (By Product)


  • Europe (By Product, By Route of Administration, By Age Group, By Distribution Channel, and By Country)


    • U.K. (By Product)

    • Germany (By Product)

    • France (By Product)

    • Italy (By Product)

    • Spain (By Product)

    • Rest of Europe (By Product)




  • Asia Pacific (By Product, By Route of Administration, By Age Group, By Distribution Channel, and By Country)




    • China (By Product)

    • Japan (By Product)

    • India (By Product)

    • Australia (By Product)

    • Southeast Asia (By Product)

    • Rest of Asia Pacific (By Product)


  • Latin America (By Product, By Route of Administration, By Age Group, By Distribution Channel, and By Country)


    • Brazil (By Product)

    • Mexico (By Product)

    • Rest of Latin America (By Product)


  • Middle East & Africa (By Product, By Route of Administration, By Age Group, By Distribution Channel, and By Country)




    • GCC (By Product)

    • South Africa (By Product)

    • Rest of MEA (By Product)




Frequently Asked Questions

Fortune Business Insights says that the global market size was USD 10.48 billion in 2022 and is projected to reach USD 15.70 billion by 2030.

In 2022, the market value of North America stood at USD 5.16 billion.

The market will exhibit a steady growth of 5.1% CAGR over the forecast period (2023-2030).

The antibiotics segment is expected to be the leading segment in this market during the forecast period.

The key driving factors of the market include the rising prevalence of the condition and the launch of advanced drugs.

Allergan, GALDERMA, and Bausch Health Companies Inc. are the leading players in the global market.

North America dominated the market share in 2022.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
  • Jul, 2023
  • 2022
  • 2019-2021
  • 150

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $6850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X